In October of 2022, OPEC+ (an organization of 23 petroleum exporting countries) agreed to the biggest oil production cut since the start of the pandemic – a worldwide reduction of petroleum exports by 2 million barrels a day. A reduction of that magnitude will likely cause the already high gas prices to soar, as well as increase the cost of so many of the products we use that are made from refined petroleum, such as plastic. Laboratories are especially vulnerable to the availability of oil-based byproducts because lab testing requires far too much plastic, especially pipette tips and microwell plates.
Many of the largest suppliers of pipette tips have informed customers of a 30-35% cost increase
Such a volatile relationship adds unpredictability and unnecessary stress to medical laboratories that our healthcare system relies upon for healthy and resilient communities. The labs that we value most in our healthcare system are left to wonder, will there be enough plastic supplies? And, what will it cost?
There is, however, another option.
Instead of reacting from a precarious position, laboratories have it within their power to control their supply of plastic consumables without the threat of fluctuating price increases and other variables that are influenced by events that may occur at any moment far beyond the lab. Smart labs are instead shifting to a proactive posture, one in which they control their most critical supplies in order to remain focused on their science and impact.
The key is mitigating dependency on plastic distributors all together.

